TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.910
+0.020 (1.06%)
At close: Sep 5, 2025, 4:00 PM
1.920
+0.010 (0.52%)
After-hours: Sep 5, 2025, 7:32 PM EDT

TScan Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-136.78-127.5-89.22-66.22-48.63-26.13
Upgrade
Depreciation & Amortization
3.114.115.365.143.331.23
Upgrade
Loss (Gain) From Sale of Assets
-----0
Upgrade
Loss (Gain) From Sale of Investments
-5.11-3.9-1.07---
Upgrade
Stock-Based Compensation
11.929.555.214.552.520.52
Upgrade
Other Operating Activities
1.691.860.760.26--
Upgrade
Change in Accounts Payable
2.131.99-0.050.530.011.13
Upgrade
Change in Unearned Revenue
-6.96-2.8211.89-9.03-6.5419.44
Upgrade
Change in Other Net Operating Assets
3.815.885.77-1.730.630.79
Upgrade
Operating Cash Flow
-126.18-110.82-61.36-66.5-48.68-3.02
Upgrade
Capital Expenditures
-5.07-3.83-3.15-4.23-9.94-4.24
Upgrade
Investment in Securities
11.98-48.79-57.61---
Upgrade
Investing Cash Flow
6.91-52.61-60.76-4.23-9.94-4.24
Upgrade
Long-Term Debt Issued
-32.46-29.35--
Upgrade
Long-Term Debt Repaid
--17.14----
Upgrade
Net Debt Issued (Repaid)
15.3115.31-29.35--
Upgrade
Issuance of Common Stock
1.835.1843.130.3389.940.29
Upgrade
Other Financing Activities
29.4158.2792.32-0.32--
Upgrade
Financing Cash Flow
46.51208.77135.4429.36189.670.29
Upgrade
Net Cash Flow
-72.7745.3313.33-41.37131.05-6.97
Upgrade
Free Cash Flow
-131.25-114.65-64.5-70.73-58.62-7.26
Upgrade
Free Cash Flow Margin
-1885.53%-4071.27%-306.45%-522.56%-578.03%-669.22%
Upgrade
Free Cash Flow Per Share
-2.31-2.03-1.35-2.94-5.03-7.93
Upgrade
Cash Interest Paid
2.522.8830.66--
Upgrade
Levered Free Cash Flow
-83.62-68.97-41.83-42.84-33.43-5.85
Upgrade
Unlevered Free Cash Flow
-81.67-66.69-39.48-42.1-33.43-5.85
Upgrade
Change in Working Capital
-1.025.0517.61-10.23-5.921.36
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q